Pascal Neuville, Domain Therapeutics CEO

Up­dat­ed: A GPCR start­up out of France and Cana­da scores its Se­ries A af­ter 14 years of wheel­ing and deal­ing

Hav­ing al­ready nailed down mul­ti­ple li­cens­ing and col­lab­o­ra­tion deals with Big Phar­ma gi­ants like Bris­tol My­ers Squibb and Pfiz­er, a France- and Que­bec-based GPCR biotech …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA